Irja Johansson

1.3k total citations
10 papers, 487 citations indexed

About

Irja Johansson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Irja Johansson has authored 10 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Irja Johansson's work include Angiogenesis and VEGF in Cancer (4 papers), Neuroblastoma Research and Treatments (3 papers) and Cell Adhesion Molecules Research (3 papers). Irja Johansson is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Neuroblastoma Research and Treatments (3 papers) and Cell Adhesion Molecules Research (3 papers). Irja Johansson collaborates with scholars based in Sweden, Italy and Germany. Irja Johansson's co-authors include Sven Påhlman, Anna‐Karin Olsson, Lena Claesson‐Welsh, Johan Dixelius, Chunsik Lee, Eewa Nånberg, Erik Lavenius, Carolina Gestblom, Cornelia Oellig and Ingemar Björk and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Journal of Neurochemistry.

In The Last Decade

Irja Johansson

10 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irja Johansson Sweden 9 299 117 106 96 62 10 487
Annika Jalava Finland 12 367 1.2× 82 0.7× 51 0.5× 53 0.6× 39 0.6× 13 582
Sherri Lynn Hubbard Canada 11 289 1.0× 43 0.4× 26 0.2× 78 0.8× 93 1.5× 12 487
Colin Ong Canada 6 477 1.6× 53 0.5× 272 2.6× 63 0.7× 57 0.9× 6 834
Nanae Izumi Japan 10 615 2.1× 95 0.8× 90 0.8× 69 0.7× 449 7.2× 21 959
M. Lynn Weir Canada 8 216 0.7× 35 0.3× 51 0.5× 28 0.3× 143 2.3× 12 396
Kimiko Takei Japan 12 327 1.1× 46 0.4× 18 0.2× 81 0.8× 137 2.2× 17 546
Uli Schmidt Germany 12 524 1.8× 100 0.9× 21 0.2× 108 1.1× 52 0.8× 38 716
Boris A. Hesser Germany 7 433 1.4× 91 0.8× 54 0.5× 25 0.3× 279 4.5× 7 663
Bogdan Yatsula United States 7 387 1.3× 45 0.4× 23 0.2× 37 0.4× 132 2.1× 16 529
Stacey C. Yang United States 9 553 1.8× 72 0.6× 18 0.2× 92 1.0× 100 1.6× 9 757

Countries citing papers authored by Irja Johansson

Since Specialization
Citations

This map shows the geographic impact of Irja Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irja Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irja Johansson more than expected).

Fields of papers citing papers by Irja Johansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irja Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irja Johansson. The network helps show where Irja Johansson may publish in the future.

Co-authorship network of co-authors of Irja Johansson

This figure shows the co-authorship network connecting the top 25 collaborators of Irja Johansson. A scholar is included among the top collaborators of Irja Johansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irja Johansson. Irja Johansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Casazza, Andrea, Xi Fu, Irja Johansson, et al.. (2011). Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models. Arteriosclerosis Thrombosis and Vascular Biology. 31(4). 741–749. 92 indexed citations
2.
Dixelius, Johan, Anna‐Karin Olsson, Åsa Thulin, et al.. (2006). Minimal Active Domain and Mechanism of Action of the Angiogenesis Inhibitor Histidine-Rich Glycoprotein. Cancer Research. 66(4). 2089–2097. 54 indexed citations
3.
Mittelholzer, Christian, et al.. (2005). Recovery of Swedish Equine arteritis viruses from semen by cell culture isolation and RNA transfection. Journal of Virological Methods. 133(1). 48–52. 6 indexed citations
4.
Olsson, Anna‐Karin, Irja Johansson, Helena Åkerud, et al.. (2004). The Minimal Active Domain of Endostatin Is a Heparin-Binding Motif that Mediates Inhibition of Tumor Vascularization. Cancer Research. 64(24). 9012–9017. 47 indexed citations
5.
Olsson, Anna‐Karin, Johan Dixelius, Irja Johansson, et al.. (2004). A Fragment of Histidine-Rich Glycoprotein Is a Potent Inhibitor of Tumor Vascularization. Cancer Research. 64(2). 599–605. 83 indexed citations
6.
Johansson, Irja, et al.. (1999). Human Achaete-Scute Homologue 1 (HASH-1) Is Downregulated in Differentiating Neuroblastoma Cells. Biochemical and Biophysical Research Communications. 256(3). 557–563. 37 indexed citations
8.
Lavenius, Erik, Carolina Gestblom, Irja Johansson, Eewa Nånberg, & Sven Påhlman. (1995). Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.. PubMed. 6(6). 727–36. 85 indexed citations
9.
Hedborg, Fredrik, P. G. Lindgren, Irja Johansson, et al.. (1992). N‐myc Gene Amplification in Neuroblastoma: A Clinical Approach Using Ultrasound Guided Cutting Needle Biopsies Collected at Diagnosis. Medical and Pediatric Oncology. 20(4). 292–300. 31 indexed citations
10.
Johansson, Karl‐Erik, Irja Johansson, & Ulf B. Göbel. (1990). Evaluation of different hybridization procedures for the detection of mycoplasma contamination in cell cultures. Molecular and Cellular Probes. 4(1). 33–42. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026